INS and Hyperglycemia: That 2/10 also reported hyperglycemia reflects previous data suggesting that these individuals retain a robust capacity for insulin production but have defects in glucose-stimulated insulin secretion, which could have effects not only in insulin secretion during hyperglycemia but also the suppression of insulin during hypoglycemia (cite Valerio 2004 and Carmody) [12, 13].